Adiponectin ameliorates experimental periodontitis in diet-induced obesity mice

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Zhang, Lan ^a,b   Meng, Shu ^a,b   Tu, Qisheng ^a   Yu, Liming ^a   Tang, Yin ^a,b   Dard, Michel M ^c   Kim, Sung Hoon ^d   Valverde, Paloma ^e   Zhou, Xuedong ^b   Chen, Jake ^a,f  

^a TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^b SICHUAN UNIVERSITY   (China)

^c NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^d Kyung Hee University   (South Korea)

^e WENTWORTH INSTITUTE OF TECHNOLOGY   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FORKHEAD BOX O1; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; NUCLEAR PROTEIN; RECOMBINANT ADIPONECTIN; RECOMBINANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ADIPONECTIN; FOXO1 PROTEIN, MOUSE;

ALVEOLAR BONE LOSS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY METABOLISM; GENE EXPRESSION; IN VITRO STUDY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; OBESITY; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIODONTITIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BONE DEVELOPMENT; CELL LINE; COMPLICATION; DRUG EFFECTS; GENETICS; LIPID DIET; METABOLISM; OSTEOCLAST;

ADIPONECTIN; ANIMALS; CELL LINE; CYTOKINES; DIET, HIGH-FAT; FORKHEAD TRANSCRIPTION FACTORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; OBESITY; OSTEOCLASTS; OSTEOGENESIS; PERIODONTITIS; RNA, MESSENGER;

EID: 84901334180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097824     Document Type: Article

References (47)

1. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ (2012) Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 91: 914-920.
2. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17: 4-12.
3. Mealey BL (2006) Periodontal disease and diabetes. A two-way street. J Am Dent Assoc 137 Suppl: 26S-31S.
4. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946. (Pubitemid 32756432)
5. Yamauchi T KJ, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769. (Pubitemid 36735700)
6. Yamaguchi N, Kukita T, Li YJ, Kamio N, Fukumoto S, et al. (2008) Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett 582: 451-456.
7. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME (2004) Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316: 924-929. (Pubitemid 38368041)
8. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935. (Pubitemid 32472900)
9. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599. (Pubitemid 30353893)
10. Zimmermann GS, Bastos MF, Dias Goncalves TE, Chambrone L, Duarte PM (2013) Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. J Periodontol 84: 624-633.
11. Saito T, Yamaguchi N, Shimazaki Y, Hayashida H, Yonemoto K, et al. (2008) Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res 87: 319-322.
12. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094-2099. (Pubitemid 33643677)
13. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, et al. (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143: 998-1007. (Pubitemid 34164048)
14. Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ, et al. (2011) Inflammatory Cytokines, Adiponectin, Insulin Resistance and Metabolic Control after Periodontal Intervention in Patients with Type 2 Diabetes and Chronic Periodontitis. Internal Medicine 50: 1569-1574.
15. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289: 1504-1508.
16. Ducy P, Schinke T, Karsenty G (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289: 1501-1504.
17. Shu RZ, Zhang F, Wang F, Feng DC, Li XH, et al. (2009) Adiponectin deficiency impairs liver regeneration through attenuating STAT3 phosphorylation in mice. Lab Invest 89: 1043-1052.
18. Ren W, Li X, Wang F, Qiao JN, Dang SY, et al. (2006) Generation of adiponectin gene knock-out and LacZ gene knock-in mouse model. Prog Biochem Biophys 33: 846-853. (Pubitemid 44788239)
19. Tu Q, Zhang J, Dong LQ, Saunders E, Luo E, et al. (2011) Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of AKT1. J Biol Chem 286: 12542-53.
20. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, et al. (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21: 1648-1656. (Pubitemid 44484610)
21. Luo E, Hu J, Bao C, Li Y, Tu Q, et al. (2012) Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits. Acta Biomater 8: 734-743.
22. Kajimura D, Lee HW, Riley KJ, Arteaga-Solis E, Ferron M, et al. (2013) Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 17: 901-915.
23. Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, et al. (2006) APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8: 516-523.
24. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci USA 104: 20466-20471.
25. Li CH, Amar S (2007) Morphometric, histomorphometric, and microcomputed tomographic analysis of periodontal inflammatory lesions in a murine model. J Periodontol 78: 1120-1128.
26. Tu Q, Zhang J, Paz J, Wade K, Yang P, et al. (2008) Haploinsufficiency of Runx2 results in bone formation decrease and different BSP expression pattern changes in two transgenic mouse models. J Cell Physiol 217: 40-47.
27. Tu Q, Zhang J, Fix A, Brewer E, Li YP, et al. (2009) Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells. J Cell Physiol 218: 135-145.
28. Kousteni S (2012) FoxO1, the transcriptional chief of staff of energy metabolism. Bone 50: 437-443.
29. Hay N (2011) Interplay between FOXO, TOR, and Akt. Biochim Biophys Acta 1813: 1965-1970.
30. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792. (Pubitemid 44033298)
31. Li H, Xie H, Fu M, Li W, Guo B, et al. (2013) 25-hydroxyvitamin D3 ameliorates periodontitis by modulating the expression of inflammation- associated factors in diabetic mice. Steroids 78: 115-120.
32. Bartell S, Han L, Warren A, Crawford J, Iyer S, et al. (2012) Gain or loss of FoxO function in osteoclasts alter bone mass in mice. ASBMR 2012 Annual Meeting: 284.
33. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, et al. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901. (Pubitemid 35460788)
34. Hirotani H, Tuohy NA, Woo JT, Stern PH, Clipstone NA (2004) The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 279: 13984-13992. (Pubitemid 38468932)
35. Miyazaki T, Bub JD, Uzuki M, Iwamoto Y (2005) Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochemical and Biophysical Research Communications 333: 79-87. (Pubitemid 40813449)
36. Saxena NK, Fu PP, Nagalingam A, Wang J, Handy J, et al. (2010) Adiponectin modulates c-Jun N- terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology 139: 1762-1773.
37. Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, et al. (2005) Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309: 99-109. (Pubitemid 41191227)
38. Kang EH, Lee YJ, Kim TK, Chang CB, Chung JH, et al. (2010) Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Research & Therapy 12: R231.
39. Bobbert P, Antoniak S, Schultheiss HP, Rauch U (2008) Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelia cells. Journal of Molecular and Cellular Cardiology 44: 388-394. (Pubitemid 351226195)
40. Park PH, Huang H, McMullen MR, Bryan K, Nagy LE (2008) Activation of cyclic-AMP response element binding protein contributes to adiponectin- stimulated interleukin-10 expression in RAW 264.7 macrophages. J Leukoc Biol 83: 1258-1266. (Pubitemid 351960358)
41. Subedi A1, Kim MJ, Nepal S, Lee ES, Kim JA, et al. (2013) Globular adiponectin modulates expression of progammed cell death 4 and miR-21 in RAW 264.7 macrophages through the MAPK/NF-KB pathway. FEBS Letters 587: 1556-1561.
42. Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, et al. (2009) Metabolic syndrome and periodontitis: is oxidative stress a common link? J Dent Res 88: 503-518.
43. Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31: 266-300.
44. Toker H, Ozdemir H, Eren K, Ozer H, Sahin G (2009) N-acetylcysteine, a thiol antioxidant, decreases alveolar bone loss in experimental periodontitis in rats. J Periodontol 80: 672-678.
45. Manolagas SC, Almeida M (2007) Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol 21: 2605-2614. (Pubitemid 350035144)
46. Galli C, Passeri G, Macaluso GM (2011) FoxOs, Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena? J Periodontal Res 46: 397-406.
47. Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, et al. (2005) A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 54: 194-199. (Pubitemid 40174847)